Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 3:16:241-248.
doi: 10.1016/j.ibneur.2024.01.006. eCollection 2024 Jun.

Risk of depression after Parkinson's disease, stroke, multiple sclerosis, and migraine in an Iranian population and assess psychometric characteristics of three prevalent depression questionnaires

Affiliations

Risk of depression after Parkinson's disease, stroke, multiple sclerosis, and migraine in an Iranian population and assess psychometric characteristics of three prevalent depression questionnaires

Mehri Salari et al. IBRO Neurosci Rep. .

Abstract

Objective: We aim to evaluate the prevalence of depression in disorders including multiple sclerosis (MS), Parkinson's disease (PD), migraine, and stroke. Also, we detect risk factors for depression occurrence within each disorder. Moreover, we compare the risk factors in these four common neurologic disorders. In advance, we assess the three surveys in order to better comprehend their distinctions.

Background: Depression is a globally prevalent Psychologic disorder and common co-morbidity in neurological diseases. However, it is mostly underdiagnosed in chronic patients and causes numerous adverse effects.

Methods: We used the database of neurology specialty clinics in a hospital in Tehran, the largest city of Iran. Five hundred nineteen patients, including 105 PD patients, 101 patients with stroke, 213 cases with MS, and 100 Migraine patients, were assessed. They were asked about their chief characteristics and disease-specific variables that may cause depression. Moreover, depression criteria were measured with three internationally used scales to study their variances.

Results: Overall, the prevalence of depression in PD, stroke, MS, and migraine, according to the BDI-II scale, were 43.8%, 38.6%, 45.1%, 37.6%, and according to HDRS scale, were 56.2%, 51.5%, 39.4%, and 43.6% respectively. Finally, according to DSM-XC the depression prevalence were 64.8%, 34.7%, 36.2%, and 67.3% respectively. Possible risk factors of depression were lower educational level, disease severity, socioeconomic level, marital or employment status, female gender, higher age, and consumption of some specific drugs.

Conclusion: Depression is a widespread disorder in chronic neurologic conditions. Our data suggests the odds of depression in neurologic disorders depend on the characteristics of the patient and the features of the disease.

Keywords: Depression; Migraine; Multiple Sclerosis; Parkinson Disease; Stroke.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Prevalence of depression within four disorders according to three questionnaires.

References

    1. Peveler R. ABC of psychological medicine: Depression in medical patients. BMJ. 2002;325(7356):149–152. doi: 10.1136/bmj.325.7356.149. - DOI - PMC - PubMed
    1. Kessler R.C., Bromet E.J. The Epidemiology of Depression Across Cultures. Annu Rev. Public Health. 2013;34(1):119–138. doi: 10.1146/annurev-publhealth-031912-114409. - DOI - PMC - PubMed
    1. Friedrich M.J. Depression Is the Leading Cause of Disability Around the World. JAMA. 2017;317(15):1517. doi: 10.1001/jama.2017.3826. - DOI - PubMed
    1. Viguera A.C., Fan Y., Thompson N.R., et al. Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute. Psychosomatics. 2018;59(4):369–378. doi: 10.1016/j.psym.2017.12.003. - DOI - PubMed
    1. Costello C.G., Scott C.B. Primary and Secondary Depression: A Review. Can. J. Psychiatry. 1991;36(3):210–217. doi: 10.1177/070674379103600310. - DOI - PubMed

LinkOut - more resources